A Study to Evaluate Safety and Efficacy of PF-06826647 For Moderate To Severe Plaque Psoriasis

NCT03895372 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
179
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Pfizer